var data={"title":"Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Virology, epidemiology, and pathogenesis of JC polyomavirus, BK polyomavirus, and other human polyomaviruses</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/contributors\" class=\"contributor contributor_credentials\">Hans H Hirsch, MD, MSc</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/contributors\" class=\"contributor contributor_credentials\">Martin S Hirsch, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/contributors\" class=\"contributor contributor_credentials\">Anna R Thorner, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jun 12, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H3730944\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Polyomavirus infections have been detected in vertebrate hosts including rodents, cattle, birds, monkeys, and primates. Despite some common features shared with papillomaviruses, including an oncogenic potential, polyomaviruses are now recognized as members of the separate genus <em>Polyomavirus</em> in the Polyomaviridae family of the ungrouped DNA viruses [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The virology, epidemiology, and pathogenesis of human polyomavirus (HPyV) infections will be provided here. An overview of the clinical manifestations and diagnosis of polyomavirus (PyV) infections is presented separately. Disease manifestations caused by HPyVs, including progressive multifocal leukoencephalopathy, PyV-associated nephropathy, and ureteral stenosis, are discussed in detail elsewhere. (See <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults#H4\" class=\"medical medical_review\">&quot;Natalizumab for relapsing-remitting multiple sclerosis in adults&quot;, section on 'Risk of PML'</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Treatment and prognosis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3730951\"><span class=\"h1\">CLASSIFICATION</span></p><p class=\"headingAnchor\" id=\"H516190086\"><span class=\"h2\">Human polyomaviruses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple species of human polyomavirus (HPyV) have been identified:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 1, called BK polyomavirus (BKPyV), and human polyomavirus 2, called JC polyomavirus (JCPyV), were named after the initials of the patients from whom they were first isolated in 1971 [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 3, called KI polyomavirus (KIPyV), and human polyomavirus 4, called WU polyomavirus (WUPyV), were named after the institutions of their first discovery in 2007 (Karolinska Institute, Stockholm, Sweden [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/4\" class=\"abstract_t\">4</a>], and Washington University St. Louis, USA) [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/4,5\" class=\"abstract_t\">4,5</a>]. (See <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections#H190971454\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;, section on 'Disease associations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 5, called Merkel cell polyomavirus (MCPyV) was named after its detection in the tissues of patients with Merkel cell carcinoma in 2009 [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/6\" class=\"abstract_t\">6</a>]. (See <a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma#H5\" class=\"medical medical_review\">&quot;Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma&quot;, section on 'Merkel cell polyomavirus'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 6 (HPyV6) and human polyomavirus 7 (HPyV7) were found in normal skin in 2010 [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/7\" class=\"abstract_t\">7</a>]. HPyV6 has not been associated with any diseases, but HPyV7 has been associated with a pruritic rash and viremia in lung transplant recipients [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/8\" class=\"abstract_t\">8</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 8 is called TS polyomavirus (TSPyV) because it was identified in association with trichodysplasia spinulosa, a rare skin disease of immunocompromised patients [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/9-11\" class=\"abstract_t\">9-11</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 9 (HPyV9) was identified in 2011 in the blood and urine of an asymptomatic kidney transplant recipient; further investigation revealed HPyV9 in the blood of a few other immunocompromised patients [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/12\" class=\"abstract_t\">12</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 10 (HPyV10) was independently described in stool samples from children in Mexico (MXPyV) and in Malawi (MWPyV), but their possible association with diarrhea is debated as they are also detected in normal feces [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 11 (HPyV11) is better known as Saint Louis polyomavirus (STLPyV) and was detected in 2013 in stool samples; its clinical significance remains unknown [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 12 (HPyV12) was detected in stool samples in 2013 and is possibly associated with diarrhea [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomavirus 13 (HPyV13), also called New Jersey polyomavirus, was reported in 2014 [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/14\" class=\"abstract_t\">14</a>]. The virus was detected using high-throughput nucleic acid sequencing of a muscle biopsy specimen from a pancreas transplant recipient who presented with systemic vasculitis, myositis, and retinal blindness. (See <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections#H190971454\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;, section on 'Disease associations'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H516190092\"><span class=\"h2\">SV40</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A simian polyomavirus virus, SV40, was discovered in 1960 as a contaminant of poliovirus and adenovirus vaccines and has been used as an experimental model of a DNA tumor virus and cell transformation. Despite human exposure to SV40 through contaminated attenuated poliovirus and adenovirus vaccines in the past, and possibly in wildlife reserves and animal facilities [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/15\" class=\"abstract_t\">15</a>], serologic data do not support the independent circulation of SV40 in humans. Its possible role in human diseases including cancer has been controversial. By contrast, infections with the human polyomaviruses are widespread with seropositivity rates ranging from 30 percent to more than 90 percent in healthy adults. (See <a href=\"#H3730972\" class=\"local\">'Geographic distribution'</a> below.)</p><p class=\"headingAnchor\" id=\"H3730958\"><span class=\"h1\">VIROLOGY</span></p><p class=\"headingAnchor\" id=\"H516190099\"><span class=\"h2\">Structure and genome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Polyomavirus (PyV) virions are small, nonenveloped icosahedral particles of 40 to 45 nm diameter that can endure heating to 50&deg;C for 30 minutes with little effect on infectivity [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/1,16\" class=\"abstract_t\">1,16</a>]. The circular double-stranded DNA genome of approximately 5000 base pairs can be divided into three parts:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The noncoding control region (NCCR) regulates the expression of the viral early and late genes in concert with the differentiation and activation of the host cell.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The early viral gene region (EVGR) encodes the regulatory nonstructural proteins called small T and large T antigen, which interact with cellular target proteins to shift the host cell into S phase to recruit metabolic building blocks and the host cell DNA polymerase for efficient viral genome replication.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The late viral gene region (LVGR) encodes the capsid proteins VP-1, VP-2, and VP-3, which are assembled in the nucleus, releasing approximately 10,000 to 100,000 virions by cell lysis [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/17\" class=\"abstract_t\">17</a>]. The LVGR of BK polyomavirus (BKPyV) and JC polyomavirus (JCPyV) also encodes a small cytoplasmic protein called agnoprotein, which appears to have multiple regulatory functions [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/18,19\" class=\"abstract_t\">18,19</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Several HPyVs have been shown to encode microRNAs that appear to regulate viral and host gene expression [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p>The NCCR is of archetype configuration in immunocompetent hosts but may be genetically rearranged in immunodeficient patients with PyV-associated nephropathy or progressive multifocal leukoencephalopathy [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/21,22\" class=\"abstract_t\">21,22</a>]. In vivo, rearranged NCCRs are associated with higher plasma BK viral loads and more advanced nephropathy in kidney transplant recipients. In vitro, the rearranged NCCR is sufficient to increase JCPyV and BKPyV EVGR expression, accelerate viral genome replication rates, and cause more cytopathic damage.</p><p class=\"headingAnchor\" id=\"H516190549\"><span class=\"h2\">Viral proteins</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The small and large T antigens play a key role in the activation of PyV replication in oncogenic transformation and host DNA instability. It is also used as a target for various diagnostic studies such as viral load determination and immunohistochemistry. Similarly, the capsid VP-1 protein has been informative for defining PyV serotypes, cellular immune recognition, neutralizing antibodies, and diagnostic antibody responses [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/21,23-32\" class=\"abstract_t\">21,23-32</a>].</p><p class=\"headingAnchor\" id=\"H516190568\"><span class=\"h2\">Receptor usage and cellular uptake</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The polyomaviruses use different glycosylated receptors, which may be located on proteins or lipids. BKPyV uses an N-linked glycoprotein containing an alpha 2-3-linked sialic acid as a receptor [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/33\" class=\"abstract_t\">33</a>]. JCPyV also uses a linear sialylated pentasaccharide chain in addition to the serotonergic 5HT2A receptor, which is present on oligodendrocytes, lymphocytes, kidney, and lung cells [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/34,35\" class=\"abstract_t\">34,35</a>]. PyV uptake occurs by endocytosis for which JCPyV uses clathrin-coated pits that form after virus binding to the cell surface; BKPyV uses invaginations of the cell membrane (caveolae) for endocytosis [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/33,36\" class=\"abstract_t\">33,36</a>]. The receptors of the other human polyomaviruses are presently unknown.</p><p class=\"headingAnchor\" id=\"H3730965\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many adults have serologic evidence of human polyomavirus (HPyV) infection, but, although the rates generally increase with increasing age, there are differences depending on the virus, geographic distribution, and recent virus replication. (See <a href=\"#H3730972\" class=\"local\">'Geographic distribution'</a> below and <a href=\"#H3730979\" class=\"local\">'Transmission'</a> below.)</p><p>BK polyomavirus (BKPyV) and JC polyomavirus (JCPyV) are known to persist latently after primary infection [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/37\" class=\"abstract_t\">37</a>], but it is not known whether all other polyomaviruses (PyVs) also establish latency. BKPyV and JCPyV urinary shedding is detectable in up to 10 to 30 percent of healthy blood donors at the time of blood donation, with median urine viral loads of 3500 (3.5 log<sub>10</sub>) <span class=\"nowrap\">copies/mL</span> and 50,000 (4.6 log<sub>10</sub>) <span class=\"nowrap\">copies/mL,</span> respectively [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,39\" class=\"abstract_t\">38,39</a>]. In individuals with altered immune status, including pregnant women and patients receiving immunosuppressive drugs or chemotherapy, urinary shedding occurs in more than 50 percent; urine viral loads often increase to values higher than 7 log<sub>10</sub> <span class=\"nowrap\">copies/mL,</span> and &quot;decoy cells&quot; (urothelial or tubular epithelial cells with an enlarged nucleus and large basophilic intranuclear inclusions) may be detectable by urine cytology (<a href=\"image.htm?imageKey=ID%2F83969\" class=\"graphic graphic_diagnosticimage graphicRef83969 \">image 1</a>) [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/40-42\" class=\"abstract_t\">40-42</a>]. This increase in urinary shedding is more pronounced for BKPyV than JCPyV in the setting of transplantation, particularly after kidney and hematopoietic cell transplantation [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/41-43\" class=\"abstract_t\">41-43</a>], but it may be entirely asymptomatic. (See <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections#H5\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;, section on 'Viruria'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">&quot;Ureteral stenosis due to BK virus infection among kidney transplant recipients&quot;</a>.)</p><p>While persistent urinary shedding of JCPyV appears to be common in immunocompetent individuals [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,39,44\" class=\"abstract_t\">38,39,44</a>], JC viremia or manifestations of organ-invasive disease are rarely observed. Extensive local virus replication in the brain leads to the development of progressive multifocal leukoencephalopathy (PML) [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/3,45,46\" class=\"abstract_t\">3,45,46</a>]. While there is a good correlation of BK viruria and viremia with BKPyV-associated diseases, this is not the case for JCPyV-associated diseases including JCPyV nephropathy [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/40,47\" class=\"abstract_t\">40,47</a>], and, in particular, there is no consistent correlation between PML and JC viruria and viremia. PML is discussed in detail separately. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Treatment and prognosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3730972\"><span class=\"h2\">Geographic distribution</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seroprevalence studies have detected antibodies to JCPyV <span class=\"nowrap\">and/or</span> BKPyV in 30 to 90 percent of adults in the United States and Europe [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,48-50\" class=\"abstract_t\">38,48-50</a>]. However, differences in the age distributions of antibodies specific for these two viruses suggest that they circulate independently [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/51,52\" class=\"abstract_t\">51,52</a>]. (See <a href=\"#H516190899\" class=\"local\">'Seroprevalence by age'</a> below.)</p><p class=\"headingAnchor\" id=\"H516190662\"><span class=\"h3\">Serotypes and subtypes</span></p><p class=\"headingAnchor\" id=\"H516190668\"><span class=\"h4\">BKPyV</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>At least four major serotypes of BKPyV have been detected based on differences in the major capsid protein VP-1, but, using genotyping, additional subtypes and subgroups could be distinguished. Subtypes of BKPyV and JCPyV may reflect different geographical exposure risks and migration patterns of the human population [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/53,54\" class=\"abstract_t\">53,54</a>]. BKPyV subtype I is the most frequently detected subtype [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/21,38,53\" class=\"abstract_t\">21,38,53</a>]. A subgroup of subtype I <span class=\"nowrap\">(I/b-2)</span> has been detected primarily in European and American populations, whereas subgroup <span class=\"nowrap\">I/c</span> predominates in Asian populations [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,55\" class=\"abstract_t\">38,55</a>]. Among subtype IV isolates, subgroup <span class=\"nowrap\">IV/c-2</span> is more prevalent among Americans and Europeans, whereas the other subgroups are more common in Asian populations [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/55\" class=\"abstract_t\">55</a>]. Differences among the subtypes may have an impact on neutralizing capacity as well as on serologic assays using VP1-based antigens [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,56,57\" class=\"abstract_t\">38,56,57</a>].</p><p class=\"headingAnchor\" id=\"H516190674\"><span class=\"h4\">JCPyV</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>JCPyV appears to have only one major serotype, but 12 subtypes have been found in specific geographic regions [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/58\" class=\"abstract_t\">58</a>]. Genotypes may differ in sequences by approximately 1 to 3 percent and show distinctive geographic preponderance. JCPyV type 1 is found in the United States, type 4 in the United States and Europe, type 2 in Asia, and types 3 and 6 in Africa [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/59\" class=\"abstract_t\">59</a>].</p><p>Using a complete viral genome analysis of 65 JCPyV DNA sequences, three superclusters were detected and were designated types A, B, and C [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/58\" class=\"abstract_t\">58</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Type A, found mainly in European and Mediterranean strains</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Type B, consisting of a minor European subtype (B1-c), all seven Asian subtypes (B1-a, -b, -d, B2, MY, CY, and SC), and the major African subtype (Af2)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Type C derived from western Africa (Af1)</p><p/><p class=\"headingAnchor\" id=\"H3730979\"><span class=\"h1\">TRANSMISSION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Virologic and epidemiologic studies suggest that there is no animal reservoir for BK polyomavirus (BKPyV) or JC polyomavirus (JCPyV), but this has not been evaluated in detail for other human polyomaviruses (HPyVs).</p><p class=\"headingAnchor\" id=\"H516190899\"><span class=\"h2\">Seroprevalence by age</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seroprevalence studies have helped to define the typical timing of infection with polyomaviruses (PyVs):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The seroprevalence of BKPyV antibodies increases sharply during childhood between 2 and 4 years of age from less than 20 percent to more than 90 percent and then levels off during adulthood [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,60,61\" class=\"abstract_t\">38,60,61</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>JCPyV-specific antibodies tend to increase around the age of 10 years and then steadily increase during adulthood to 50 to 70 percent [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,49,62-64\" class=\"abstract_t\">38,49,62-64</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Merkel cell polyomavirus (MCPyV) may be acquired early during childhood with rates of 9 percent in 1- to 4-year-olds, increasing to 35 percent in 4- to 13-year-olds [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/65\" class=\"abstract_t\">65</a>]; during adulthood, rates of seropositivity are 50 to 90 percent [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/50,66\" class=\"abstract_t\">50,66</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The rate of seropositivity for KI polyomavirus (KIPyV)and WU polyomavirus (WUPyV) are similarly high among adults, and, for KIPyV, rises with increasing age [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/67,68\" class=\"abstract_t\">67,68</a>].</p><p/><p class=\"headingAnchor\" id=\"H516190905\"><span class=\"h2\">Possible routes of transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Despite considerable research, the routes of transmission have not been clearly identified for any of the HPyVs. Oral <span class=\"nowrap\">and/or</span> respiratory transmission has been strongly implicated for BKPyV, JCPyV, KIPyV, and WUPyV, whereas direct skin contact has been suggested for MCPyV, human polyomavirus 6, human polyomavirus 7, and TS polyomavirus [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/69\" class=\"abstract_t\">69</a>]. Studies in children and adults have shown that some polyomaviruses are frequently present in stool samples [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/70-73\" class=\"abstract_t\">70-73</a>] and urban sewage [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/74,75\" class=\"abstract_t\">74,75</a>]; these findings suggest that fecal-oral transmission may occur. In addition, BKPyV, JCPyV, WUPyV, and MCPyV have been detected in tonsillar tissue, which suggests that either an oral or a respiratory route of transmission is possible [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/76-79\" class=\"abstract_t\">76-79</a>].</p><p>There is evidence for JCPyV transmission within families from parents to children, but approximately half of the infections appear to occur outside of families [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/80,81\" class=\"abstract_t\">80,81</a>]. The possibility of prenatal and perinatal transmission of BKPyV or JCPyV has been discussed in view of the hypothesized viremia following primary infection. This has been supported by studies that identified BKPyV IgM in newborns [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/82\" class=\"abstract_t\">82</a>]. BKPyV genome sequences have been detected in different tissues of aborted fetuses, with some discordance between the rates for VP-1 and the noncoding control region [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/83\" class=\"abstract_t\">83</a>]. However, there is currently no definitive evidence that prenatal polyomavirus transmission to the fetus contributes to miscarriage or congenital disease or that perinatal transmission of JCPyV or BKPyV occurs frequently.</p><p class=\"headingAnchor\" id=\"H3730986\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Following infection and expression of the viral small and large T antigen, susceptible host cells engage in active polyomavirus (PyV) replication. BK polyomavirus (BKPyV) activates host cell metabolism and induces a series of morphologic changes that coincide with the localization of the large T antigen in the nucleus, increases in nuclear size upon viral genome replication, and the generation of intranuclear inclusions due to capsid assembly. These cytopathically altered cells increase in size, round up, and detach from the basement membrane <span class=\"nowrap\">and/or</span> neighboring cells and eventually lyse, releasing infectious progeny [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/1\" class=\"abstract_t\">1</a>].</p><p>The kinetics of BKPyV replication are likely to be host cell dependent, and the replication cycle is in the range of 48 to 72 hours in tubular epithelial cells in vitro and in vivo [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/17,84-86\" class=\"abstract_t\">17,84-86</a>]. The JC polyomavirus (JCPyV) replication cycle appears to be slower, at least in vitro, ranging from five to seven days in primary glia-derived astrocytes. Reactivation of latent or low-level persisting PyV infection is thought to require activating signals in the host cells that may be linked to differentiation, inflammation, stress, and target transcription control regions present in the noncoding control region [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/22,87\" class=\"abstract_t\">22,87</a>].</p><p>In immunocompetent hosts, PyV replication is controlled by limiting spread of progeny virus, especially hematogenous virion spread, through neutralizing antibodies and deleting replicating host cells by cytotoxic T cell responses. In the setting of inadequate immune control, unchecked virus replication is critical for the extent and duration of local damage and the spread to neighboring cells and further dissemination including via the bloodstream.</p><p>During primary JCPyV and BKPyV infections of mucosal surfaces (eg, of the respiratory tract, oropharynx, <span class=\"nowrap\">and/or</span> gastrointestinal tract), viremic spread occurs to other tissues and organs. For BKPyV and JCPyV, this includes the urinary tract as a principal site [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/37\" class=\"abstract_t\">37</a>]. Direct evidence for primary viremia is lacking, but indirect support is provided by the observation that approximately 30 to 50 percent of humans without kidney disease have detectable BKPyV <span class=\"nowrap\">and/or</span> JCPyV sequences in kidney tissue obtained at surgery or autopsy [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/37\" class=\"abstract_t\">37</a>] as well as by the frequent shedding of BKPyV and JCPyV in the urine of healthy adults [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38,39,88,89\" class=\"abstract_t\">38,39,88,89</a>].</p><p>For BKPyV and JCPyV, urine viral loads ranging from 6 log<sub>10</sub> to more than 9 log<sub>10</sub> <span class=\"nowrap\">copies/mL</span> may be without adverse consequences, clinical symptoms, and signs, which is not the case for virus replication in kidney or brain tissue. JCPyV-infected B cells and other mononuclear cells may play a role in the transport and reactivation en route to the central nervous system (CNS) [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/90,91\" class=\"abstract_t\">90,91</a>]. Once within the CNS, either resulting from de novo seeding or by spontaneous local reactivation (eg, in the setting of HIV infection), JCPyV infects oligodendrocytes and astrocytes as well as granule cell neurons [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/22,92\" class=\"abstract_t\">22,92</a>]. (See <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections#H5\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;, section on 'Viruria'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a> and <a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">&quot;Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation&quot;</a>.)</p><p>Human polyomavirus infection may result in different disease manifestations, which depend on whether or not there is sustained viral replication [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/23,93,94\" class=\"abstract_t\">23,93,94</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Progressive multifocal leukoencephalopathy (PML) is caused by high-level replication of JCPyV, mostly in oligodendrocytes, without significant inflammation. This cytopathic pattern is typically seen in patients with advanced AIDS who have PML. However, signs of inflammation have been described in patients with PML treated with immunosuppressive drugs used for transplantation or the treatment of autoimmune diseases (eg, multiple sclerosis).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>BKPyV-associated nephropathy in kidney transplant recipients is characterized by high-level virus replication and a significant inflammatory response due to necrosis, denudation of the basement membrane, and infiltration of granulocytes and lymphocytes.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immune reconstitution inflammatory syndrome is characterized by an exaggerated inflammatory response to abundant PyV antigen upon brisk recovery of immunity [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/95,96\" class=\"abstract_t\">95,96</a>]. The prototypes are BKPyV-associated hemorrhagic cystitis after allogenic hematopoietic cell transplantation [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/95,96\" class=\"abstract_t\">95,96</a>] and the unmasking of PML after the start of antiretroviral therapy for HIV infection [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/97\" class=\"abstract_t\">97</a>] or following the removal of <a href=\"topic.htm?path=natalizumab-drug-information\" class=\"drug drug_general\">natalizumab</a> through plasmapheresis in multiple sclerosis patients [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/98\" class=\"abstract_t\">98</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Oncogenic effects of PyVs are characterized by viral early gene expression activating host cells, but without subsequent late gene expression and cytopathic release of progeny virus. The prototype of this uncoupling is the genetic truncation of the Merkel cell polyomavirus genome permitting viral small and large T antigen expression but not late viral gene expression due to chromosomal integration or mutations [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/6\" class=\"abstract_t\">6</a>]. Uncoupling from capsid protein expression, assembly, and cell lysis may also underlie BKPyV-associated urothelial cancers [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/99\" class=\"abstract_t\">99</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some autoimmune diseases have been proposed to result from an aberrant response to self-triggered by PyV large T antigens complexed to host cell DNA [<a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/100,101\" class=\"abstract_t\">100,101</a>].</p><p/><p>As noted, ongoing replication with increasing urine and plasma viral loads are the hallmark of PyV-associated nephropathy and hemorrhagic cystitis and provide noninvasive markers for diagnosis and monitoring. Similarly, PML is characterized by ongoing replication of JCPyV in the CNS. By contrast, the oncogenic and the autoimmune pathologies are not dependent on concurrent PyV replication.</p><p class=\"headingAnchor\" id=\"H3732899\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Human polyomaviruses (HPyVs) are members of a genus of DNA viruses in the Polyomaviridae family. The most common polyomaviruses (PyVs) to cause human infections are JC polyomavirus (JCPyV) and BK polyomavirus (BKPyV). Other PyVs include Merkel cell polyomavirus (MCPyV) as well as TS polyomavirus (TSPyV), KI polyomavirus (KIPyV), and WU polyomavirus (WUPyV). (See <a href=\"#H3730944\" class=\"local\">'Introduction'</a> above and <a href=\"#H3730951\" class=\"local\">'Classification'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>PyV virions are small, nonenveloped icosahedral particles of 40 to 45 nm diameter that can endure heating to 50&deg;C for 30 minutes with little effect on infectivity. The circular double-stranded DNA genome of approximately 5000 base pairs can be divided into three parts: the noncoding control region, the early viral gene region, and the late viral gene region. (See <a href=\"#H516190099\" class=\"local\">'Structure and genome'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Many adults have serologic evidence of HPyV infection, but rates differ depending on the virus, the age group, geographic distribution, and recent virus replication. (See <a href=\"#H3730965\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Despite considerable research, the routes of transmission have not been clearly identified for any of the HPyVs. Oral <span class=\"nowrap\">and/or</span> respiratory transmission have been strongly implicated for BKPyV, JCPyV, KIPyV, and WUPyV, whereas direct skin contact has been suggested for MCPyV, human polyomavirus 6, human polyomavirus 7, and TSPyV. (See <a href=\"#H516190905\" class=\"local\">'Possible routes of transmission'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary infection of BKPyV and JCPyV may be associated with viremia that results in seeding of the end-organs (eg, kidney), where a clinically latent infection is established. (See <a href=\"#H3730986\" class=\"local\">'Pathogenesis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li class=\"breakAll\">Imperiale MJ, Major EO. Polyomaviruses. In: Fields Virology, 5th ed, Knipe DM, Howley PM (Eds), Lippincott Williams &amp; Wilkins, Philadelpha 2007. Vol 2, p.2263.</li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/2\" class=\"nounderline abstract_t\">Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; 1:1253.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/3\" class=\"nounderline abstract_t\">Padgett BL, Walker DL, ZuRhein GM, et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; 1:1257.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/4\" class=\"nounderline abstract_t\">Allander T, Andreasson K, Gupta S, et al. Identification of a third human polyomavirus. J Virol 2007; 81:4130.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/5\" class=\"nounderline abstract_t\">Gaynor AM, Nissen MD, Whiley DM, et al. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog 2007; 3:e64.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/6\" class=\"nounderline abstract_t\">Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008; 319:1096.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/7\" class=\"nounderline abstract_t\">Schowalter RM, Pastrana DV, Pumphrey KA, et al. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010; 7:509.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/8\" class=\"nounderline abstract_t\">Ho J, Jedrych JJ, Feng H, et al. Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis 2015; 211:1560.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/9\" class=\"nounderline abstract_t\">van der Meijden E, Janssens RW, Lauber C, et al. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog 2010; 6:e1001024.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/10\" class=\"nounderline abstract_t\">Osswald SS, Kulick KB, Tomaszewski MM, Sperling LC. Viral-associated trichodysplasia in a patient with lymphoma: a case report and review. J Cutan Pathol 2007; 34:721.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/11\" class=\"nounderline abstract_t\">van der Meijden E, Horv&aacute;th B, Nijland M, et al. Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients. J Infect Dis 2017; 215:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/12\" class=\"nounderline abstract_t\">Scuda N, Hofmann J, Calvignac-Spencer S, et al. A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol 2011; 85:4586.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/13\" class=\"nounderline abstract_t\">Ehlers B, Wieland U. The novel human polyomaviruses HPyV6, 7, 9 and beyond. APMIS 2013; 121:783.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/14\" class=\"nounderline abstract_t\">Mishra N, Pereira M, Rhodes RH, et al. Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy. J Infect Dis 2014; 210:1595.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/15\" class=\"nounderline abstract_t\">Engels EA, Switzer WM, Heneine W, Viscidi RP. Serologic evidence for exposure to simian virus 40 in North American zoo workers. J Infect Dis 2004; 190:2065.</a></li><li class=\"breakAll\">System, E.E.P.A. 2010. Polyomaviruses. In: Swiss Institute of Bioinformatics.</li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/17\" class=\"nounderline abstract_t\">Funk GA, Gosert R, Comoli P, et al. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8:2368.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/18\" class=\"nounderline abstract_t\">Unterstab G, Gosert R, Leuenberger D, et al. The polyomavirus BK agnoprotein co-localizes with lipid droplets. Virology 2010; 399:322.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/19\" class=\"nounderline abstract_t\">Khalili K, White MK, Sawa H, et al. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol 2005; 204:1.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/20\" class=\"nounderline abstract_t\">Seo GJ, Fink LH, O'Hara B, et al. Evolutionarily conserved function of a viral microRNA. J Virol 2008; 82:9823.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/21\" class=\"nounderline abstract_t\">Gosert R, Rinaldo CH, Funk GA, et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205:841.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/22\" class=\"nounderline abstract_t\">Gosert R, Kardas P, Major EO, Hirsch HH. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate. J Virol 2010; 84:10448.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/23\" class=\"nounderline abstract_t\">Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3:611.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/24\" class=\"nounderline abstract_t\">Weinreb DB, Desman GT, Amolat-Apiado MJ, et al. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol 2006; 34:201.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/25\" class=\"nounderline abstract_t\">Chen Y, Trofe J, Gordon J, et al. BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol 2008; 42:198.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/26\" class=\"nounderline abstract_t\">Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007; 7:1131.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/27\" class=\"nounderline abstract_t\">Luo C, Bueno M, Kant J, et al. Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis. J Virol 2009; 83:2285.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/28\" class=\"nounderline abstract_t\">Luo C, Bueno M, Kant J, Randhawa P. Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol 2008; 80:1850.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/29\" class=\"nounderline abstract_t\">Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995; 26:671.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/30\" class=\"nounderline abstract_t\">Bodaghi S, Comoli P, B&ouml;sch R, et al. Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. J Clin Microbiol 2009; 47:2577.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/31\" class=\"nounderline abstract_t\">Comoli P, Azzi A, Maccario R, et al. Polyomavirus BK-specific immunity after kidney transplantation. Transplantation 2004; 78:1229.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/32\" class=\"nounderline abstract_t\">Comoli P, Hirsch HH, Ginevri F. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13:569.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/33\" class=\"nounderline abstract_t\">Dugan AS, Eash S, Atwood WJ. Update on BK virus entry and intracellular trafficking. Transpl Infect Dis 2006; 8:62.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/34\" class=\"nounderline abstract_t\">Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306:1380.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/35\" class=\"nounderline abstract_t\">Neu U, Maginnis MS, Palma AS, et al. Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 2010; 8:309.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/36\" class=\"nounderline abstract_t\">Neu U, Stehle T, Atwood WJ. The Polyomaviridae: Contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 2009; 384:389.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/37\" class=\"nounderline abstract_t\">Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147:676.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/38\" class=\"nounderline abstract_t\">Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199:837.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/39\" class=\"nounderline abstract_t\">Polo C, P&eacute;rez JL, Mielnichuck A, et al. Prevalence and patterns of polyomavirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 2004; 10:640.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/40\" class=\"nounderline abstract_t\">Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation 2007; 84:323.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/41\" class=\"nounderline abstract_t\">Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347:488.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/42\" class=\"nounderline abstract_t\">Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77:238.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/43\" class=\"nounderline abstract_t\">Arthur RR, Shah KV, Charache P, Saral R. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158:563.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/44\" class=\"nounderline abstract_t\">Kitamura T, Sugimoto C, Kato A, et al. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol 1997; 35:1255.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/45\" class=\"nounderline abstract_t\">ASTROM KE, MANCALL EL, RICHARDSON EP Jr. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81:93.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/46\" class=\"nounderline abstract_t\">ZURHEIN G, CHOU SM. PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE. Science 1965; 148:1477.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/47\" class=\"nounderline abstract_t\">Lautenschlager I, Jahnukainen T, Kardas P, et al. A case of primary JC polyomavirus infection-associated nephropathy. Am J Transplant 2014; 14:2887.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/48\" class=\"nounderline abstract_t\">Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5:e1000363.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/49\" class=\"nounderline abstract_t\">Knowles WA. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv Exp Med Biol 2006; 577:19.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/50\" class=\"nounderline abstract_t\">Pastrana DV, Tolstov YL, Becker JC, et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009; 5:e1000578.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/51\" class=\"nounderline abstract_t\">Nicol JT, Robinot R, Carpentier A, et al. Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus. Clin Vaccine Immunol 2013; 20:363.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/52\" class=\"nounderline abstract_t\">Nicol JT, Leblond V, Arnold F, et al. Seroprevalence of human Malawi polyomavirus. J Clin Microbiol 2014; 52:321.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/53\" class=\"nounderline abstract_t\">Zhong S, Randhawa PS, Ikegaya H, et al. Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol 2009; 90:144.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/54\" class=\"nounderline abstract_t\">Yogo Y, Sugimoto C, Zhong S, Homma Y. Evolution of the BK polyomavirus: epidemiological, anthropological and clinical implications. Rev Med Virol 2009; 19:185.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/55\" class=\"nounderline abstract_t\">Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA, et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002; 73:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/56\" class=\"nounderline abstract_t\">Randhawa P, Viscidi R, Carter JJ, et al. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol 2009; 90:634.</a></li><li class=\"breakAll\">Cinque P, Dumoulin A, Hirsch HH. Diagnosis of Polyomavirus Infection, Replication and Disease. In: Jerome K, Laboratory Diagnosis of Viral Infections (Ed), Informa Healthcare USA, New York 2009. p.401.</li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/58\" class=\"nounderline abstract_t\">Sugimoto C, Hasegawa M, Kato A, et al. Evolution of human Polyomavirus JC: implications for the population history of humans. J Mol Evol 2002; 54:285.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/59\" class=\"nounderline abstract_t\">Cubitt CL. Molecular genetics of the BK virus. Adv Exp Med Biol 2006; 577:85.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/60\" class=\"nounderline abstract_t\">Schmidt T, Adam C, Hirsch HH, et al. BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication. Am J Transplant 2014; 14:1334.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/61\" class=\"nounderline abstract_t\">Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/62\" class=\"nounderline abstract_t\">Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/63\" class=\"nounderline abstract_t\">Carter JJ, Paulson KG, Wipf GC, et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009; 101:1510.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/64\" class=\"nounderline abstract_t\">Hirsch HH, Kardas P, Kranz D, Leboeuf C. The human JC polyomavirus (JCPyV): virological background and clinical implications. APMIS 2013; 121:685.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/65\" class=\"nounderline abstract_t\">Chen T, Hedman L, Mattila PS, et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011; 50:125.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/66\" class=\"nounderline abstract_t\">Tolstov YL, Pastrana DV, Feng H, et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009; 125:1250.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/67\" class=\"nounderline abstract_t\">Neske F, Prifert C, Scheiner B, et al. High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors. BMC Infect Dis 2010; 10:215.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/68\" class=\"nounderline abstract_t\">Nguyen NL, Le BM, Wang D. Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerg Infect Dis 2009; 15:1199.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/69\" class=\"nounderline abstract_t\">Wieland U, Mauch C, Kreuter A, et al. Merkel cell polyomavirus DNA in persons without merkel cell carcinoma. Emerg Infect Dis 2009; 15:1496.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/70\" class=\"nounderline abstract_t\">Vanchiere JA, Abudayyeh S, Copeland CM, et al. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol 2009; 47:2388.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/71\" class=\"nounderline abstract_t\">Babakir-Mina M, Ciccozzi M, Alteri C, et al. Excretion of the novel polyomaviruses KI and WU in the stool of patients with hematological disorders. J Med Virol 2009; 81:1668.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/72\" class=\"nounderline abstract_t\">Vanchiere JA, Nicome RK, Greer JM, et al. Frequent detection of polyomaviruses in stool samples from hospitalized children. J Infect Dis 2005; 192:658.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/73\" class=\"nounderline abstract_t\">Wong AS, Cheng VC, Yuen KY, et al. High frequency of polyoma BK virus shedding in the gastrointestinal tract after hematopoietic stem cell transplantation: a prospective and quantitative analysis. Bone Marrow Transplant 2009; 43:43.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/74\" class=\"nounderline abstract_t\">Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000; 66:238.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/75\" class=\"nounderline abstract_t\">Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, et al. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75:10290.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/76\" class=\"nounderline abstract_t\">Goudsmit J, Wertheim-van Dillen P, van Strien A, van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/77\" class=\"nounderline abstract_t\">Babakir-Mina M, Ciccozzi M, Bonifacio D, et al. Identification of the novel KI and WU polyomaviruses in human tonsils. J Clin Virol 2009; 46:75.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/78\" class=\"nounderline abstract_t\">Kantola K, Sadeghi M, Lahtinen A, et al. Merkel cell polyomavirus DNA in tumor-free tonsillar tissues and upper respiratory tract samples: implications for respiratory transmission and latency. J Clin Virol 2009; 45:292.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/79\" class=\"nounderline abstract_t\">Monaco MC, Jensen PN, Hou J, et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72:9918.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/80\" class=\"nounderline abstract_t\">Kitamura T, Kunitake T, Guo J, et al. Transmission of the human polyomavirus JC virus occurs both within the family and outside the family. J Clin Microbiol 1994; 32:2359.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/81\" class=\"nounderline abstract_t\">Kunitake T, Kitamura T, Guo J, et al. Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. J Clin Microbiol 1995; 33:1448.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/82\" class=\"nounderline abstract_t\">Gibson PE, Field AM, Gardner SD, Coleman DV. Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy. J Clin Pathol 1981; 34:674.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/83\" class=\"nounderline abstract_t\">Boldorini R, Allegrini S, Miglio U, et al. BK virus sequences in specimens from aborted fetuses. J Med Virol 2010; 82:2127.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/84\" class=\"nounderline abstract_t\">Low J, Humes HD, Szczypka M, Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004; 323:182.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/85\" class=\"nounderline abstract_t\">Bernhoff E, Gutteberg TJ, Sandvik K, et al. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 2008; 8:1413.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/86\" class=\"nounderline abstract_t\">Seemayer CA, Seemayer NH, D&uuml;rm&uuml;ller U, et al. BK virus large T and VP-1 expression in infected human renal allografts. Nephrol Dial Transplant 2008; 23:3752.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/87\" class=\"nounderline abstract_t\">Ferenczy MW, Marshall LJ, Nelson CD, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012; 25:471.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/88\" class=\"nounderline abstract_t\">Markowitz RB, Thompson HC, Mueller JF, et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167:13.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/89\" class=\"nounderline abstract_t\">Markowitz RB, Eaton BA, Kubik MF, et al. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol 1991; 65:4515.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/90\" class=\"nounderline abstract_t\">Chapagain ML, Nerurkar VR. Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier. J Infect Dis 2010; 202:184.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/91\" class=\"nounderline abstract_t\">Marshall LJ, Dunham L, Major EO. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. J Gen Virol 2010; 91:3042.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/92\" class=\"nounderline abstract_t\">W&uuml;thrich C, Cheng YM, Joseph JT, et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2009; 68:15.</a></li><li class=\"breakAll\">Hirsch HH. Polyoma and Papilloma Virus Infections after Hematopoietic Stem Cell or Solid Organ Transplantation. In: Transplant Infections, Bowden P, Ljungman P, Snydman DR (Eds), Lippincott Williams &amp; Wilkins, 2010. p.465.</li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/94\" class=\"nounderline abstract_t\">Hirsch HH. BK virus: opportunity makes a pathogen. Clin Infect Dis 2005; 41:354.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/95\" class=\"nounderline abstract_t\">Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opinion Organ Transplant 2000; 5:210.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/96\" class=\"nounderline abstract_t\">Hirsch HH, Kaufmann G, Sendi P, Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004; 38:1159.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/97\" class=\"nounderline abstract_t\">Safdar A, Rubocki RJ, Horvath JA, et al. Fatal immune restoration disease in human immunodeficiency virus type 1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 2002; 35:1250.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/98\" class=\"nounderline abstract_t\">Kappos L, Bates D, Hartung HP, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007; 6:431.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/99\" class=\"nounderline abstract_t\">Geetha D, Tong BC, Racusen L, et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation 2002; 73:1933.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/100\" class=\"nounderline abstract_t\">Bredholt G, Olaussen E, Moens U, Rekvig OP. Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen: footprints of a common molecular and cellular process? Arthritis Rheum 1999; 42:2583.</a></li><li><a href=\"https://www.uptodate.com/contents/virology-epidemiology-and-pathogenesis-of-jc-polyomavirus-bk-polyomavirus-and-other-human-polyomaviruses/abstract/101\" class=\"nounderline abstract_t\">Fredriksen K, Osei A, Sundsfjord A, et al. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice. Eur J Immunol 1994; 24:66.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 8299 Version 7.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H3732899\"><span>SUMMARY</span></a></li><li><a href=\"#H3730944\" id=\"outline-link-H3730944\">INTRODUCTION</a></li><li><a href=\"#H3730951\" id=\"outline-link-H3730951\">CLASSIFICATION</a><ul><li><a href=\"#H516190086\" id=\"outline-link-H516190086\">Human polyomaviruses</a></li><li><a href=\"#H516190092\" id=\"outline-link-H516190092\">SV40</a></li></ul></li><li><a href=\"#H3730958\" id=\"outline-link-H3730958\">VIROLOGY</a><ul><li><a href=\"#H516190099\" id=\"outline-link-H516190099\">Structure and genome</a></li><li><a href=\"#H516190549\" id=\"outline-link-H516190549\">Viral proteins</a></li><li><a href=\"#H516190568\" id=\"outline-link-H516190568\">Receptor usage and cellular uptake</a></li></ul></li><li><a href=\"#H3730965\" id=\"outline-link-H3730965\">EPIDEMIOLOGY</a><ul><li><a href=\"#H3730972\" id=\"outline-link-H3730972\">Geographic distribution</a><ul><li><a href=\"#H516190662\" id=\"outline-link-H516190662\">- Serotypes and subtypes</a><ul><li><a href=\"#H516190668\" id=\"outline-link-H516190668\">BKPyV</a></li><li><a href=\"#H516190674\" id=\"outline-link-H516190674\">JCPyV</a></li></ul></li></ul></li></ul></li><li><a href=\"#H3730979\" id=\"outline-link-H3730979\">TRANSMISSION</a><ul><li><a href=\"#H516190899\" id=\"outline-link-H516190899\">Seroprevalence by age</a></li><li><a href=\"#H516190905\" id=\"outline-link-H516190905\">Possible routes of transmission</a></li></ul></li><li><a href=\"#H3730986\" id=\"outline-link-H3730986\">PATHOGENESIS</a></li><li><a href=\"#H3732899\" id=\"outline-link-H3732899\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/8299|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83969\" class=\"graphic graphic_diagnosticimage\">- BK virus decoy cells</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">Clinical manifestations and diagnosis of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=natalizumab-for-relapsing-remitting-multiple-sclerosis-in-adults\" class=\"medical medical_review\">Natalizumab for relapsing-remitting multiple sclerosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections\" class=\"medical medical_review\">Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-clinical-features-and-diagnosis-of-merkel-cell-neuroendocrine-carcinoma\" class=\"medical medical_review\">Pathogenesis, clinical features, and diagnosis of Merkel cell (neuroendocrine) carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-and-management-of-bk-virus-induced-polyomavirus-induced-nephropathy-in-kidney-transplantation\" class=\"medical medical_review\">Prevention and management of BK virus-induced (polyomavirus-induced) nephropathy in kidney transplantation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-treatment-and-prognosis\" class=\"medical medical_review\">Progressive multifocal leukoencephalopathy: Treatment and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ureteral-stenosis-due-to-bk-virus-infection-among-kidney-transplant-recipients\" class=\"medical medical_review\">Ureteral stenosis due to BK virus infection among kidney transplant recipients</a></li></ul></div></div>","javascript":null}